Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer. - Xu, Shouping; Yu, Keda; Liu, Lei; Wang, Qin; Wu, Xiaohui; Chen, Yihai; Li, Guozheng; Zhang, Xin; Wei, Bo; Fu, Zitong; Nanding, Abiyasi; Zhao, Zuxianglan; et al. (Advanced Science, 2026)